Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)
Condition: HER2-negative Gastric Cancer Intervention: Drug: Capecitabine, camrelizumab Sponsor: Ruijin Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials